Global Whole Exome Sequencing Market 2023
根据最新估计, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% 从 2023 到 2029. 顶级市场公司…
The Global Virology Testing Market is poised for growth, with a projected increase from USD 12.48 billion in 2022 兑美元 13.65 十亿 2029, reflecting a modest compound annual growth rate (复合年增长率) 的 1.2% during the period from 2023 到 2029. Virology testing encompasses a range of diagnostic techniques employed to identify viruses, including cell culture, antibody detection, antigen detection, nucleic acid detection, gene sequencing, and hemagglutination assays.
The COVID-19 pandemic has significantly propelled market growth, primarily driven by the escalating number of cases and the emergence of new viral strains. In response, companies have introduced diagnostic tests and kits, expanding their product portfolios to meet the growing demand. 此外, collaborations between industry players and governments have played a pivotal role in driving market expansion, fostering innovation, and enhancing testing capabilities.
The prevalence of viral diseases, coupled with the continuous emergence of new pathogens, is expected to be a key driver for market growth. 此外, the approval of new virology testing products by regulatory authorities will further contribute to market expansion, providing healthcare professionals with advanced tools for accurate and timely diagnosis.
然而, it is important to note that stringent regulations governing virology testing may pose challenges for market players. Compliance with these regulations, including quality control measures and adherence to safety standards, requires significant investments and resources.
The market is segmented based on component, diagnostic technique, 最终用户, and geography.
Segmentation by Component
仪器
Assay Kits and Consumables
Segmentation by Diagnostic Technique
Molecular Diagnostics Method – PCR-based methods, NGS-based methods
Immunoassay-based Method
Mass Spectroscopy-based Method
其他的
Segmentation by End User
Hospitals and Clinics
Diagnostic Laboratories
其他的
Segmentation by Geography
北美 – 美国, 加拿大, 墨西哥
欧洲 – 英国, 德国, 法国, 意大利, 西班牙, and Rest of Europe
亚太 – 中国, 日本, 印度, 澳大利亚, 韩国, and Rest of Asia-Pacific
拉美 – 巴西, 阿根廷, and Rest of Latin America
中东和非洲 – GCC, 南非, and Rest of Middle East and Africa
The PCR-based molecular diagnostic methods segment is expected to gain a significant market share. PCR methods are widely used for pathogen detection, including viruses, and have improved diagnostic testing by reducing time and increasing accuracy. The COVID-19 pandemic has further boosted the segment’s growth, with RT-PCR being the preferred diagnostic method for COVID-19. Pharmaceutical and biotech companies are actively researching new molecules for COVID-19 treatment. Initiatives such as the launch of “”ViraGen”” in India and the development of a portable PCR molecular assay for monkeypox virus detection by Anitoa indicate the segment’s growth potential.
The regional market has grown due to advanced diagnostic methods, healthcare spending, favorable policies, and advanced laboratories. The United States’ 右&D activities and viral infection cases, like influenza and HIV, have fueled demand for testing, leading to market growth. The virology testing market in the region is expected to continue growing.
The virology testing market is fragmented and has many major players. Currently, a small number of these major players dominate the industry and hold significant market share. Some of the companies operating in this market include Abbott Laboratories, bioMerieux S.A., Bio-Rad Laboratories Inc., Cepheid Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Fujirebio Diagnostics Inc., Hologic Inc., Qiagen N.V., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech plc, Vircell S.L., 和别的.
QuantuMDx Group Limited announced the launch of its Q-POC SARS-CoV-2, Flu A/B & RSV Assay in May 2022. This respiratory panel test is compatible with the Q-POC platform, providing rapid point-of-care testing capabilities in clinical and non-clinical settings.
In January 2022, InTec introduced the AQ+ Covid-19 Ag Rapid Test, an ultra-sensitive SARS-CoV-2 Rapid Antigen Test for professional use. This test enables healthcare professionals or laypersons to quickly and conveniently detect Covid-19, contributing to the ongoing efforts against the pandemic.
Get a detailed picture of the Global Virology Testing Market
Identify segments/areas to invest in over the forecast period in the Global Virology Testing Market
了解竞争环境, 市场的领先参与者
Excel 格式的跨场景分析易用性的市场预估
三个月的战略咨询和研究支持
为单用户许可证提供打印验证
目录
数字和表格
部分 1. 介绍
1.1 描述
1.2 研究目的
1.3 细分市场
1.4 报告的考虑年份
1.5 货币
1.6 主要目标受众
部分 2. 研究方法论
部分 3. 执行摘要
部分 4. 市场概况
部分 5. GLOBAL VIROLOGY TESTING MARKET BY COMPONENT
5.1 Assay kits and consumables
5.2 仪器
部分 6. GLOBAL VIROLOGY TESTING MARKET BY DIAGNOSTIC TECHNIQUE
6.1 Immunoassay-based method
6.2 Mass spectroscopy-based method
6.3 Molecular diagnostics method
6.4 其他的
部分 7. GLOBAL VIROLOGY TESTING MARKET BY END USER
7.1 Diagnostic laboratories
7.2 Hospitals and clinics
7.3 其他的
部分 8. GLOBAL VIROLOGY TESTING MARKET BY GEOGRAPHY
8.1 北美
8.2 欧洲
8.3 亚太
8.4 拉美
8.5 中东和非洲
部分 9. 公司简介
9.1 Abbott Laboratories
9.2 bioMerieux S.A.
9.3 Bio-Rad Laboratories, 公司.
9.4 Cepheid Inc.
9.5 DiaSorin S.p.A.
9.6 F. Hoffmann-La Roche AG
9.7 Fujirebio Diagnostics, 公司.
9.8 Hologic Inc.
9.9 Qiagen N.V.
9.10 Siemens Healthineers AG
9.11 Thermo Fisher Scientific Inc.
9.12 Trinity Biotech plc
9.13 Vircell S.L.
免责声明
Abbott Laboratories
bioMerieux S.A.
Bio-Rad Laboratories, 公司.
Cepheid Inc.
DiaSorin S.p.A.
F. Hoffmann-La Roche AG
Fujirebio Diagnostics, 公司.
Hologic Inc.
Qiagen N.V.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Trinity Biotech plc
Vircell S.L.
报告属性 | 细节 |
---|---|
市场规模 (2022) | 美元 12.48 十亿 |
基准年 | 2022 |
预测年份 | 2023-2029 |
复合年增长率 (2023-2029) | 1.24% |
页数 | 23 |
细分依据 | Component, Diagnostic Technique, 终端用户, Geography |
覆盖地区 | 全球的 |
行业参与者 | Abbott Laboratories, bioMerieux S.A., Bio-Rad Laboratories Inc., Cepheid Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Fujirebio Diagnostics Inc., Hologic Inc., Qiagen N.V., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech plc, Vircell S.L. |
根据最新估计, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% 从 2023 到 2029. 顶级市场公司…
The global continuous bioprocessing market, 就收入而言, 预计增长 17.9 每年通过百分比 2029, 根据最新的估计. 包括顶级市场公司简介…
根据最新估计, the global GvHD treatment market is predicted to be growing at a CAGR of over 6% 从 2023 到 2029. 顶级市场公司简介…
请填写我们的表格,我们会尽快回复您.